📣 VC round data is live. Check it out!

Align Technology Valuation Multiples

Discover Align Technology's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Cooper Companies, Olympus, Fresenius Medical Care, Smith & Nephew and more.

Align Technology Overview

About Align Technology

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.


Founded

1997

HQ

United States

Employees

20.9K

Financials (LTM)

Revenue: $4B
EBITDA: $1B

EV

$11B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Align Technology Financials

Align Technology reported last 12-month revenue of $4B and EBITDA of $1B.

In the same LTM period, Align Technology generated $3B in gross profit, $1B in EBITDA, and $781M in net income.

Revenue (LTM)


Align Technology P&L

In the most recent fiscal year, Align Technology reported revenue of $4B and EBITDA of $1B.

Align Technology is profitable as of last fiscal year, with gross margin of 67%, EBITDA margin of 27%, and net margin of 19%.

See analyst estimates for Align Technology
LTMLast FY202320242025202620272028
Revenue$4B$4B$4B$4B$4B
Gross Profit$3B$3B$3B$3B$3B
Gross Margin70%67%70%70%67%
EBITDA$1B$1B$799M$817M$823M
EBITDA Margin27%27%21%20%20%
EBIT Margin23%23%17%17%15%
Net Profit$781M$763M$445M$421M$410M
Net Margin19%19%12%11%10%

Financial data powered by Morningstar, Inc.

Align Technology Stock Performance

Align Technology has current market cap of $12B, and enterprise value of $11B.

Market Cap Evolution


Align Technology's stock price is $166.69.

Align Technology share price decreased by 4.7% in the last 30 days, and by 12.0% in the last year.

Align Technology has an EPS (earnings per share) of $10.65.

See more trading valuation data for Align Technology
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$11B$12B-1.8%-4.7%-2.8%-12.0%$10.65

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Align Technology Valuation Multiples

Align Technology trades at 2.7x EV/Revenue multiple, and 9.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Align Technology

EV / Revenue (LTM)


Align Technology Financial Valuation Multiples

As of June 3, 2026, Align Technology has market cap of $12B and EV of $11B.

Align Technology has a P/E ratio of 15.3x.

LTMLast FY202320242025202620272028
EV/Revenue2.7x2.7x2.8x2.7x2.7x
EV/EBITDA9.8x10.2x13.8x13.5x13.4x
EV/EBIT11.6x12.0x16.7x16.4x18.8x
EV/Gross Profit3.8x4.1x4.1x3.9x4.1x
P/E15.3x15.6x26.8x28.3x29.1x
EV/FCF16.5x22.4x18.1x17.7x22.4x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Align Technology Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Align Technology Margins & Growth Rates

Align Technology grew revenue by 4% and EBITDA by 9% in the last fiscal year.

In the most recent fiscal year, Align Technology reported gross margin of 67%, EBITDA margin of 27%, and net margin of 19%.

See estimated margins and future growth rates for Align Technology

Align Technology Margins

Last FY202420252026202720282029
Gross Margin67%70%67%71%
EBITDA Margin27%20%20%28%
EBIT Margin23%17%15%24%
Net Margin19%11%10%19%
FCF Margin12%16%12%22%

Align Technology Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth4%4%1%4%
Gross Profit Growth10%3%(3%)10%
EBITDA Growth9%2%1%44%
EBIT Growth9%2%(13%)70%
Net Profit Growth6%(5%)(3%)97%
FCF Growth88%2%(21%)88%

Data powered by FactSet, Inc. and Morningstar, Inc.

Align Technology Operational KPIs

Align Technology's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Align Technology's Rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Align Technology's Rule of X is 37% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Align Technology
LTMLast FY202320242025202620272028
Rule of 4031%32%---
Bessemer Rule of X37%37%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue9%9%9%9%9%
Opex to Revenue-53%53%53%53%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Align Technology Competitors

Align Technology competitors include Cooper Companies, Olympus, Fresenius Medical Care, Smith & Nephew, Zydus Lifesciences, Penumbra, Medpace, Fisher & Paykel, Solventum and Globus Medical.

Most Align Technology public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Cooper Companies3.4x3.3x10.9x10.4x
Olympus2.0x2.0x8.7x11.2x
Fresenius Medical Care1.0x1.0x5.2x5.3x
Smith & Nephew2.5x2.4x9.6x9.3x
Zydus Lifesciences4.2x4.1x13.4x15.8x
Penumbra8.6x8.2x46.5x43.8x
Medpace4.8x4.6x21.7x21.0x
Fisher & Paykel9.2x9.2x26.6x26.6x

This data is available for Pro users. Sign up to see all Align Technology competitors and their valuation data.

Start Free Trial

Acquisitions by Align Technology

Align Technology has acquired 3 companies to date.

Last acquisition by Align Technology was on September 6th 2023. Align Technology acquired Cubicure for $92M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Align Technology

Cubicure
exocad
G.L. Dental Couture
Description
Cubicure GmbH is a Vienna-based pioneer in digital light processing for polymer 3D printing. Founded in 2019, it manufactures resins and printers enabling high-resolution micro-parts for medical devices, optics, and microfluidics with resolutions down to 25 microns.
exocad is a Darmstadt, Germany-based developer of dental CAD/CAM software spun off from Fraunhofer IGD in 2010. The DentalCAD platform holds an exclusive license for Fraunhofer's dental modeling technology used by thousands of labs annually for crown, bridge, and implant designs.
G.L. Dental Couture Ltd. is a Dubai-headquartered distributor of Invisalign clear aligners across Europe, the Middle East, and Africa. The company supplies orthodontic practices with Align Technology's products, including SmartTrack material aligners and digital treatment planning via ClinCheck software. G.L. Dental Couture supports thousands of providers with training, marketing materials, and logistics for adult and teen orthodontic solutions.
HQ CountryAustriaGermanyUnited Arab Emirates
HQ City
Vienna
Darmstadt
Dubai
Deal Date6 Sep 20235 Mar 202021 Feb 2017
Valuation$92M$420M$35M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Align Technology acquisitions and their M&A valuation multiples.

Start Free Trial

Investments by Align Technology

Align Technology has invested in 1 company to date.

Latest investment by Align Technology was on January 1st 2017. Align Technology invested in SmileDirectClub in their $13M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Align Technology

SmileDirectClub
SmileDirectClub
Description
SmileDirectClub Inc is engaged in the orthodontics business. It is mainly involved in the sale of aligners, impression kits, whitening gel, and retainers. The company has one operating segment, aligner products.
SmileDirectClub Inc is engaged in the orthodontics business. It is mainly involved in the sale of aligners, impression kits, whitening gel, and retainers. The company has one operating segment, aligner products.
HQ CountryUnited StatesUnited States
HQ City
Nashville, TN
Nashville, TN
Deal Date1 Jan 20171 Jul 2016
RoundSeries AUndisclosed stage
Raised$13M$47M
InvestorsAlign TechnologyAlign Technology; Gin Lane
Valuationundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Align Technology investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Align Technology

When was Align Technology founded?Align Technology was founded in 1997.
Where is Align Technology headquartered?Align Technology is headquartered in United States.
How many employees does Align Technology have?As of today, Align Technology has over 20K employees.
Who is the CEO of Align Technology?Align Technology's CEO is Joseph M. Hogan.
Is Align Technology publicly listed?Yes, Align Technology is a public company listed on Nasdaq.
What is the stock symbol of Align Technology?Align Technology trades under ALGN ticker.
When did Align Technology go public?Align Technology went public in 2001.
Who are competitors of Align Technology?Align Technology main competitors include Cooper Companies, Olympus, Fresenius Medical Care, Smith & Nephew, Zydus Lifesciences, Penumbra, Medpace, Fisher & Paykel, Solventum, Globus Medical.
What is the current market cap of Align Technology?Align Technology's current market cap is $12B.
What is the current revenue of Align Technology?Align Technology's last 12 months revenue is $4B.
What is the current revenue growth of Align Technology?Align Technology revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Align Technology?Current revenue multiple of Align Technology is 2.7x.
What is the current EBITDA of Align Technology?Align Technology's last 12 months EBITDA is $1B.
What is Align Technology's EBITDA margin?Align Technology's last 12 months EBITDA margin is 27%.
What is the current EV/EBITDA multiple of Align Technology?Current EBITDA multiple of Align Technology is 9.8x.
What is the current FCF of Align Technology?Align Technology's last 12 months FCF is $667M.
What is Align Technology's FCF margin?Align Technology's last 12 months FCF margin is 16%.
What is the current EV/FCF multiple of Align Technology?Current FCF multiple of Align Technology is 16.5x.
How many companies Align Technology has acquired to date?As of June 2026, Align Technology has acquired 3 companies.
What was the largest acquisition by Align Technology?$420M acquisition of exocad on 5th March 2020 was the largest M&A Align Technology has done to date.
What companies Align Technology acquired?Align Technology acquired exocad, Cubicure, and G.L. Dental Couture.
In how many companies Align Technology has invested to date?As of June 2026, Align Technology has invested in 1 company.
What was the last Align Technology investment?On 1st January 2017 Align Technology invested in SmileDirectClub, participating in a $13M Series A round.
In what companies Align Technology invested in?Align Technology invested in SmileDirectClub.

See public comps similar to Align Technology

Lists including Align Technology

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial